Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic patterns of metabolic dysfunction‐associated steatotic liver disease in type 2 diabetes: The impact of insulin

18 Apr 2025

Abstract excerpt

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) often leads to hepatic insulin resistance (IR), yet its link to liver-specific insulin-mediated glucose uptake (IGLU) in type 2 diabetes (T2D) remains unclear. We aimed to explore this MASLD-T2D relationship, addressing organ-specific IR for personalized management and risk prevention. METHODS: F]FDG-PET/CT imaging before and after...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes, Cardiovascular Risks, and Lipoproteins
Share to Liver Disease and Transplantation
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40251759
DOI: 10.1111/eci.70050

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic patterns of metabolic dysfunction‐associated steatotic liver disease in type 2 diabetes: The impact of insulinPMID 40251759Read ↗

Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset.Semantic proximity Read ↗

Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtypingSemantic proximity Read ↗

Hepatic and abdominal adiposity in type 2 diabetes as assessed with machine learning on CT scansSemantic proximity Read ↗

Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationSemantic proximity Read ↗

Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes.Semantic proximity Read ↗

Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease.Semantic proximity Read ↗

[Precise clinical classification of metabolic associated fatty liver disease].Semantic proximity Read ↗

Predictive value of the triglyceride-glucose index for metabolic-associated fatty liver disease in individuals with different metabolic obese phenotypesSemantic proximity Read ↗

Impact Of Thyroid Dysfunction And Diabetes On Fibrosis And Steatosis Stages In Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Association of non-invasive liver-related scores with cardiovascular disease and a four-domain cardiovascular-renal-hepatic-metabolic phenotype in patients with type 2 diabetes mellitus and MASLD.Semantic proximity Read ↗

Liver Fat Changes in Patients With Type 2 Diabetes by Presence of Genetic Hepatic Steatosis: A Post Hoc Analysis of SURPASS-3 MRI.Semantic proximity Read ↗

Intrapancreatic Fat Deposition and Metabolic Signatures Across Adiposity Phenotypes in Chinese Adults: A Computed Tomography Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.